The market crossed US$ 2.0 billion mark in 2022 and is expected to hit US$ 3.23 billion by 2030, recording a CAGR of 6.1% during the forecast period.
The Wound Care Biologics Market research report by Business Market Insights includes Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. This study provides information about the sales and revenue during the historic and forecasted period of 2022 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the Wound Care Biologics market growth.
Get a Sample Report “Wound Care Biologics Market” to 2030 @: https://www.businessmarketinsights.com/sample/BMIRE00026034
Key Players:
- Smith & Nephew plc.
- Organogenesis Inc.
- MIMEDX
- Integra LifeSciences
- Stryker Corporation
- Bioventus LLC.
- AbbVie Inc.
- Kerecis
- Merakris Therapeutics
- Medline Industries, LP
- Skye Biologics Holdings, LLC
In this report, the market has been segmented on the basis of:
- Product:
- Cellular and/or tissue-based products (CTPs)
- Keratinocytes
- Fibroblasts
- Adipose-derived stromal cells
- Others
- Biologic Skin Substitutes
- Acellular Products
- Cellular Products
- Biosynthetic Products
- Others
- Topical Agents
- Growth Factors
- Recombinant human platelet-derived growth factor-BB (rhPDGF-BB)
- Keratinocyte growth factor (KGF)
- Recombinant human epidermal growth factor (rh EGF)
- Others
- Scaffolds
- Others
- Cellular and/or tissue-based products (CTPs)
Wound Type
- Ulcers
- Diabetic Foot Ulcers
- Venous Ulcers
- Pressure Ulcers
- Others
- Traumatic Wounds
- Burns
- Post-operative incisions
- Abrasions, cuts and lacerations
- Skin irritations
- Conditions with periostomal care
- Others
- Application:
- Hydrogels
- Film Dressings
- Nanofiber-Based Dressings
- Extracellular matrix-derived biomaterials
- Others
- End User:
- Hospitals
- ASCs
- Burn Centers and Wound Clinics
- Others
- Region
- North America
- Europe
- Asia Pacific
- South & Central America
- Middle East & Africa
The wound care biologics market has undergone several significant developments, and a few of these have been mentioned below:
- In June 2021, MIMEDX (US) received approval from the Japanese Ministry of Health, Labour and Welfare for the commercialization of Epifix in Japan.
- In April 2021, Kerecis (Iceland) launched its Kerecis Omega3 GraftGuide, an intact fish skin that uniquely addresses the challenges of burn healing.
- In January 2021, Integra LifeSciences (US) acquired ACell, Inc. (US). This acquisition enabled Integra to provide more comprehensive and complex wound management solutions.
- In November 2020, Stryker Corporation (US) acquired Wright Medical Group N.V. (Netherlands), a global medical devices company focused on extremities and biologics.
The wound care biologics market is driven by several players by implementing strategic activities such as investments, new launches, mergers & acquisitions, and partnerships. Smith & Nephew plc., Organogenesis Inc., MIMEDX, Integra LifeSciences, Stryker Corporation, Bioventus LLC., AbbVie Inc., Kerecis, Merakris Therapeutics, Medline Industries, LP, Skye Biologics Holdings, LLC are among the prominent players operating in the market.
Companies Profiled in this report includes:
The report offers in-depth assessment of the growth and other aspects of the Wound Care Biologics market in important regions. The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological, and political status of the particular region. Analysts have studied the data of revenue, production, and manufacturers of each region. This section analyses region-wise revenue and volume for the forecast period of 2022 to 2030. These analyses will help the reader to understand the potential worth of investment in a particular region.
Wound Care Biologics Market: Competitive Landscape
This section of the report identifies various key manufacturers of the market. It helps the reader understand the strategies and collaborations that players are focusing on combat competition in the market. The comprehensive report provides a significant microscopic look at the market. The reader can identify the footprints of the manufacturers by knowing about the global revenue of manufacturers, during the forecast period of 2022 to 2030.
Major Key Points of Wound Care Biologics Market
- Wound Care Biologics Market Overview
- Wound Care Biologics Market Competition
- Wound Care Biologics Market, Revenue and Price Trend
- Wound Care Biologics Market Analysis by Application
- Company Profiles and Key Figures in Wound Care Biologics Market
- Market Dynamics
- Methodology and Data Source
Leading market players and manufacturers are studied to help give a brief idea about them in the report. The challenges faced by them and the reasons they are on that position is explained to help make a well-informed decision. Competitive landscape Wound Care Biologics market is given presenting detailed insights into the company profiles, developments, merges, acquisitions, economic status and best SWOT analysis.
NOTE: Our team is studying Covid-19 and its impact on various industry verticals and wherever required we will be considering Covid-19 analysis of markets and industries. Cordially get in touch for more details.
About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defence; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.
